P1118 NO EFFECT OF FALDAPREVIR ON RENAL FUNCTION IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: POOLED DATA FROM TWO PHASE III TRIALS von Zeuzem, S, Jensen, D.M, Carvalho, A, Diago, M, Feinman, S.V, Kowdley, K.V, Kao, J.-H, Maevskaya, M, Negro, F, Mantry, P, Tanaka, Y, Forton, D, Genné, D, Paik, S.W, Zehnter, E, Kuboki, M, Lee, W.M, Peng, C.-Y, Yatsuhashi, H, Stern, J.O, Datsenko, Y, Drulak, M, Voss, F, Böcher, W, Ferenci, P

Volltext

143 EFFICACY AND SAFETY OF INCREASING DOSES OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A IN TREATMENT NAIVE CHRONIC HCV PATIENTS von Flisiak, R, Feinman, S.V, Jablkowski, M, Horban, A, Kryczka, W, Halota, W, Heathcote, J.E, Mazzella, G, Vandelli, C, Liz, J.S, Crabbé, R, Scalfaro, P, Porchet, H

Volltext

Effects of Ribavirin Dose Reduction vs Erythropoietin for Boceprevir-Related Anemia in Patients With Chronic Hepatitis C Virus Genotype 1 Infection—A Randomized Trial von Poordad, Fred, Lawitz, Eric, Reddy, K. Rajender, Afdhal, Nezam H, Hézode, Christophe, Zeuzem, Stefan, Lee, Samuel S, Calleja, Jose Luis, Brown, Robert S, Craxi, Antonio, Wedemeyer, Heiner, Nyberg, Lisa, Nelson, David R, Rossaro, Lorenzo, Balart, Luis, Morgan, Timothy R, Bacon, Bruce R, Flamm, Steven L, Kowdley, Kris V, Deng, Weiping, Koury, Kenneth J, Pedicone, Lisa D, Dutko, Frank J, Burroughs, Margaret H, Alves, Katia, Wahl, Janice, Brass, Clifford A, Albrecht, Janice K, Sulkowski, Mark S

Volltext

264 INTENSIFIED DOSES OF PEGINTERFERON ALFA-2A AND/OR RIBAVIRIN ARE ASSOCIATED WITH HIGHER RATES OF SVR AND LOWER RELAPSE RATES AMONG PATIENTS WITH METABOLIC SYNDROME von Harrison, S.A, Shiffman, M.L, Rodriguez-Torres, M, Abdurakhmanov, D, Silva, G.F, Stanciu, C, Mazur, W, Feinman, S.V, Moreno, C, McKenna, M, Messinger, D, Teitz, A, Reddy, K.R

Volltext

Evaluation of the safety and efficacy of once-weekly PEG/interferon alfa-2A (PEGASYS™) for chronic hepatitis C. A multinational, randomized study von Zeuzem, S., Feinman, S.V., Rasenack, J., Heathcote, E.J., Lai, M.-Y., Gane, E., O'Grady, J., Reichen, J., Brunda, M.J.

Volltext

Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests von Blajchman, M.A, Bull, S.B, Feinman, S.V, Canadian Post-Transfusion Hepatitis Prevention Study Group

Volltext

P.258 Treatment of nonresponders/relapsers to interferon with peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in routine clinical practice: factors predicting SV... von Sherman, M., Anderson, F.H., Feinman, S.V., Kaita, K., Marotta, P., Lee, S.S., Yoshida, E.

Volltext

593 Treating chronic hepatitis C with peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin in routine clinical practice: Factors predicting SVR using multiple logistic regressio... von Lee, S.S., Powis, J., Heathcote, E.J., Sherman, M., Bailey, R.J., Feinman, S.V., Baro, V., Yoshidas, E., Witt-Sullivan, H.B., Peltekian, K.

Volltext

Removal of Hepatitis B Surface Antigen from a Contaminated Applanation Tonometer von Moniz, E., Feldman, F., Newkirk, M., Feinman, S.V., Berris, B.

Volltext

Early loss of minus HCV RNAS strand from serum parallels plus strand and is an early predictor for favorable response to α interferon (IFN) in patients with chronic hepatitis C inf... von Elkashab, M., D'Costa, L., Feinman, S.V.

Volltext

Posttransfusion hepatitis in Toronto, Canada von Feinman, S.V., Berris, B., Bojarski, S.

Volltext

Anti-HCV in post-transfusion hepatitis: deductions from a prospective study von Feinman, S.V., Berris, B., Herst, R.

Volltext

Anti-HCV in post transfusion hepatitis: deductions from a prospective study von Berris, B., Feinman, S.V.

Volltext

The Incidence of Post-Transfusion Hepatitis von Blajchman, M A, Feinman, S V, Bull, S B

Volltext

Autoantibodies anti-LKM and AMA during interferon treatment of chronic hepatitis C von Willems, B., Villeneuve, J.P., Feinman, S.V., Vincelette, J., Pomier-Layraroues, G.

Volltext

DNA: DNA hybridization method for the diagnosis of hepatitis b infection von Feinman, S.V., Berris, B., Guha, A., Sooknanan, R., Bradley, D.W., Bond, W.W., Maynard, J.E.

Volltext

Diseases of the Liver and Biliary Tract von Berris, B., Feinman, S.V.

Volltext

Longitudinal prospective study of the hepatitis B (HBsAg) carrier state von Feinman, S.V., Berris, B., Cooter, N., Sinclair, J.C., Wrobel, D.M.

Volltext

Hepatitis B surface antigen (HBsAg) in the gastrointestinal tract von Feinman, S.V., Berris, B., Sinclair, J.C., Wrobel, D.M.

Volltext

Clinical and epidemiological significance of the HBSAg (Australia antigen): carrier state von Feinman, S V, Cooter, N, Sinclair, J C, Wobel, D M, Berris, B

Volltext